Supporting our ex vivo findings in SLE patient B cells, we observed a significant increase of IgM+ early-PB frequencies and a decreased ratio of IgG+ B cells to IgM+ early-PBs (CSR ratio) under these polarizing in vitro conditions (Fig. 5F–H). The gene discussed is CD40LG; the disease is systemic lupus erythematosus.